← board
ONMD
distress 6/10 · elevated risk$0.63+3%today-80% from 52w high
Revenue
pre-revenue
Liquidity
$0M
Runway
0.0 yrs
Shares 1y
+18%
Price & events
-34.9% over 6M
CatalystRating changeDilutionFinancingdashed = today
+2.9%
1D
-8.7%
1W
+5.0%
1M
-29.1%
3M
-35.8%
6M
+9.2%
1Y
-24.6%
2Y
-93.6%
5Y
-93.6%
All
Overview
- Market Cap
- $34.29M
- Enterprise Value
- $34.23M
- Volume
- 16.04K
- 52 Week Range
- $0.45 – $3.14
- Total Shares
- 54.43M
- Float Shares
- 15.45M
- Short %
- 0.78%
- % Held by Insiders
- 70.10%
- % Held by Institutions
- 18.90%
- RVOL
- 0.05x
- Beta
- 1.14
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 0
- No catalyst news yet.
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
Shares out: 54,433,407 · 0 offerings/1y · 0 PIPEs
- none
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- no recent rating changes
Competitors
- none identified
Recent news
- none
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.